查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球生化分析仪市场
市场调查报告书
商品编码
1176599

2023-2030 年全球生化分析仪市场

Global Biochemistry Analyzers Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期内 (2023-2030)，生化分析仪的全球市场规模预计将以 6.2% 的复合年增长率增长。

生化分析仪是一种采集血液或尿液，使用试剂引起反应，并测量糖和胆固醇等各种成分的设备。 这些测试在常规健康检查和医院进行。 结果，可以获得指示疾病的早期检测和诊断、治疗效果和患者预后的客观数据。

市场动态

由于糖尿病等慢性病患者的增加、诊断服务的分散化、对POC解决方案的需求增加以及新兴市场对医疗基础设施的投资增加，生化分析仪的市场正在扩大。

诊断服务的分散化和对医疗保健基础设施投资的增加预计将推动市场的增长。

由于技术进步、对 POC 解决方案的需求增加、研发投资激增、糖尿病等慢性病的增加以及新兴市场医疗基础设施的进步，生化分析仪市场正在使用最新技术实现新的增长。产品改进。 慢性病影响着全世界数百万人，据说仅糖尿病一项就影响了 4.22 亿人。 随着全球受这些疾病影响的人数增加，对诊断测试的需求也将增加。

技术进步使生化分析仪变得更快、更小。 便携式、紧凑型生化分析仪的可用性不断提高，使医生能够建立即时诊断中心，而不是将样本送到大型实验室。

此外，床旁设备覆盖的疾病数量也在增加，这可能会增加对紧凑型分析仪的需求。 由于这些因素，以及需要进行生化测试以确认多种疾病，政府和私营公司增加的医疗保健支出可能会导致对生化分析仪等基础设施的投资增加。这是一种自然现象。

各种新产品的发布和研究正在为市场的增长做出贡献。 例如，2022年5月13日，迈瑞宣布推出BS-600M化学分析仪。 这款功能强大且高效的分析仪专为中型实验室开发，旨在提高效率、可靠性和生产力。 它结构紧凑，通量高，可实现连续样品加载，提供稳健的性能、出色的精度和准确度以及成本效益。

与生化分析仪相关的高资本成本预计会阻碍市场增长。

全球生化分析仪市场涉及仪器资本成本高，部分地区保险报销下降，以及復杂的系统集成，没有分析仪使用经验的人无法管理。设备。

生化分析仪的资金成本很高。 高端设备的成本高达 45,000 美元。 为此，医院等用户被迫租购，销量不断下降。

COVID-19 影响分析

疫情对全球金融预测、运营和危机应对策略产生了积极影响。 COVID-19 的爆发严重影响了医疗保健行业。 由于 COVID，生化分析仪市场获得了巨大收益。 病毒增加了肝损伤和呼吸系统疾病的发病率，导致对这些生化分析仪的需求增加。 主要製造商已经启动了各种研究和临床试验。 全球范围内正在发生多项举措、产品发布、合作和合併，促进了市场增长。 例如，2021 年 11 月 3 日，医疗器械和解决方案的开发商和供应商迈瑞宣布与体外诊断公司 Randox 合作，提供新的生化参数。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 诊断服务的分散化
      • 扩大对医疗保健基础设施的投资
      • 不断进步的技术进步
    • 约束因素
      • 关于全自动生化分析仪相关的副作用
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按类型

  • 全自动生化分析仪
  • 半自动生化分析仪

第八章配置

  • 台式生化分析仪
  • 落地式生化分析仪

第9章容量

  • 紧凑型生化分析仪
  • 中型生化分析仪
  • 大型生化分析仪

第 10 章应用

  • 临床诊断
  • 药物开发
  • 通过生物反应器产物检测
  • 其他

第 11 章最终用户

  • 医院
  • 诊断实验室
  • 製药和生物技术公司
  • 研究所
  • 其他

第12章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第13章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 值得关注的主要公司名单

第14章公司简介

  • F. Hoffmann-La Roche Ltd
    • 公司概况
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Beckman Coulter, Inc.
  • Horiba Medical
  • Siemens Healthineers AG
  • Hitachi High-Tech Corporation
  • EKF Diagnostics
  • Thermo Fisher Scientific Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Randox Laboratories Ltd.
  • QuidelOrtho Corporation

第15章 ataM

简介目录
Product Code: DMLE1230

Market Overview

The global biochemistry analyzer market size was valued at US$ XX million in 2023 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 6.2% during the forecast period (2023-2030).

The biochemistry analyzer is an instrument that uses a blood or urine sample and induces reactions using reagents to measure various components, such as sugar, cholesterol, etc. These tests are performed for routine health checks or at hospitals. The results provide objective data enabling early detection and diagnosis of disease and indicating the effects of treatment and patient prognosis.

Market Dynamics

The market for biochemistry analyzers is driven by the increase in the number of people affected with chronic diseases such as diabetes, decentralization of diagnostics services, increase in demand for POC solutions and the rising investment in healthcare infrastructure in emerging markets.

The decentralization of diagnostic services and rising investment in healthcare infrastructure are expected to drive the market's growth.

The biochemistry analyzers market is driven by rising advancements in technology, an increase in demand for POC solutions, a surge in research and development investments, an increasing number of chronic disorders such as diabetes, and improvements in novel products using the latest technology along with advances in medical infrastructure in emerging markets. Chronic diseases affect millions worldwide, with diabetes alone affecting 422 million people. With the number of people affected by these disorders increasing worldwide, the demand for diagnostic tests could increase.

Technological advances have resulted in biochemistry analyzers becoming faster and smaller. The rising availability of portable and smaller biochemistry analyzers has made it possible for physicians to set up their point-of-care diagnostic centers instead of sending the samples to large labs.

The number of diseases covered by point-of-care devices is also rising, thus potentially increasing the demand for small analyzers. Along with these factors, due to the necessity of performing biochemistry tests to confirm multiple disorders, rising healthcare expenditure by governments and the private sector could lead to higher investments in infrastructure such as biochemistry analyzers.

Various novel product launches and research studies contribute to the market's growth. For instance, in 13 May 2022, Mindray announced the launch of its BS-600M chemistry analyzer. This powerful yet efficient analyzer was developed for the medium size laboratories to enhance efficiency, reliability and productivity. It is compact with high throughput that allows continuous sample loading and provides robust performance, excellent precision and accuracy and high-cost efficiency.

The high capital cost associated with biochemistry analyzers is expected to hamper the market's growth.

The global market for biochemistry analyzers is restrained by the high capital cost of the machines, reduction in insurance reimbursement in some regions and shortage of skilled labor for managing the analyzers as they have complex system integration and hence can't be managed by a person without any experience of using these biochemical analyzers.

Biochemistry analyzers have a significant capital cost; high-end machines may cost as much as $45000. These high capital costs force users such as hospitals to acquire them on rental plans leading to lower sales.

COVID-19 Impact Analysis

The pandemic has positively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely affected the healthcare industry. The biochemistry analyzers market has experienced huge profits due to COVID, as the incidence of liver disorders and respiratory disorders increased due to the virus leading to the demand for these biochemistry analyzers. Key manufacturers have started various research and clinical trials. Multiple initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Nov 3, 2021, Mindray, medical devices and solutions developer and supplier, announced its partnership with in-vitro diagnostics company Randox to provide novel biochemistry parameters.

Segment Analysis

The fully automatic biochemistry analyzers-type segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The fully automatic biochemistry analyzers type segment is the highest market holder in the global biochemistry analyzers market. The global biochemistry analyzers market is segmented based on type, as fully automated and semi-automatic biochemistry analyzers. The fully automatic biochemistry analyzers segment is the largest market shareholder due to its inherent advantages over semi-automatic analyzers, increasing technological advancements and novel product launches.

The fully automatic biochemistry analyzer is that samples can be processed in single, batches or continuously. In this type of analyzer, the instrument completes the whole process automatically, from sample addition to results. It only requires the operator to put the sample on the analyzer at a specific position and start the program without manual intervention. It is convenient, less time taking, has fewer measurement errors and provides quick analysis. To maintain product differentiation, key players are introducing new technologies, such as integrated and modular clinical chemistry analyzers, which perform the work of multiple machines at a faster rate.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in July 22, 2020, Beckman Coulter announced that its novel PK7400 automated microplate system analyzer and its reagents had received U.S. Food and Drug Administration clearance. This analyzer can be utilized in blood donor centers and large laboratories. This system in this class provides high throughput for a single analyzer and processes around 300 samples per hour.

Geographical Analysis

North America holds the largest market share in the global biochemistry analyzers market.

North America dominates the global biochemistry analyzers market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively high pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure. The number of people affected with chronic disease is projected to rise to 629 million by 2045, as per the International Diabetes Federation. In the UK alone, 500 million biochemistry tests are performed yearly, with more than 50 % being for chronic diseases.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of applications of the biochemistry analyzers in several clinical diagnostics and drug development, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the biochemistry analyzers market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in January 25, 2021, Beckman Coulter, a clinical diagnostics provider, launched its tabletop analyzer, DxH 560 AL, which will minimize the small or medium-sized laboratory's resources and time constraints. This analyzer is compact and utilizes about 30% less space, offers auto-loading functionality and closed-tube aspiration capabilities, upto 50 samples can be added continually, takes less time on manual tasks and offers security against blood-borne microbes.

Competitive Landscape

The biochemistry analyzers market is highly competitive with local and global companies' presence. F. Hoffman-La Roche Ltd, Beckman Coulter, Inc., Horiba Medical, Siemens Healthineers AG, Hitachi High-Tech Corporation, EKF Diagnostics, Thermo Fisher Scientific Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Randox Laboratories Ltd., QuidelOrtho Corporation and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in December 23, 2021, Quidel Corporation, a point-of-care diagnostic solution manufacturer, announced its acquisition agreement completion with Ortho Clinical Diagnostics Holdings plc, an in vitro diagnostics company, to form QuidelOrtho.

F. Hoffman-La Roche Ltd.

Overview: Roche is a healthcare company that provides in-vitro diagnostics and supplies innovative and transformative solutions in various crucial disease areas. It works in two divisions: Pharmaceuticals and diagnostics. It was established in 1896 and is headquartered in Basel, Switzerland.

Product Portfolio:

Cobas 8000 analyzer series: These biochemistry analyzers are modular analyzers that provide a high-volume workload of over 500 samples daily with more than 440 configurations and 280 reagent positions.

Key Development: In Mar 16, 2022, Roche Diagnostics announced its partnership with SRL Diagnostics to transform its Fortis Memorial Research Institute laboratory with the integrated analyzer series of Roche.

The global biochemistry analyzers market report would provide access to approx.: 45+ market data tables, 40+ figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Decentralization of diagnostic services
      • 4.1.1.2. Increasing investment in healthcare infrastructure
      • 4.1.1.3. Rising technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. Side effects associated with Biochemistry Analyzers
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Fully Automatic Biochemistry Analyzers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Semi-Automatic Biochemistry Analyzers

8. By Configuration

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 8.1.2. Market Attractiveness Index, By Configuration
  • 8.2. Bench-Top Biochemistry Analyzers *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Floor-Standing Biochemistry Analyzers

9. By Capacity

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 9.1.2. Market Attractiveness Index, By Capacity
  • 9.2. Small-Sized Biochemistry Analyzers *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Medium-Sized Biochemistry Analyzers
  • 9.4. Large-Sized Biochemistry Analyzers

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Clinical Diagnostics *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Drug Development
  • 10.4. Bioreactor Byproduct Detection
  • 10.5. Others

11. By End-User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.1.2. Market Attractiveness Index, By End-User
  • 11.2. Hospitals *
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Diagnostic Labs
  • 11.4. Pharmaceutical and Biotechnology Companies
  • 11.5. Research Institutions
  • 11.6. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Products Benchmarking
  • 13.4. List of Key Companies to Watch

14. Company Profiles

  • 14.1. F. Hoffmann-La Roche Ltd *
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Beckman Coulter, Inc.
  • 14.3. Horiba Medical
  • 14.4. Siemens Healthineers AG
  • 14.5. Hitachi High-Tech Corporation
  • 14.6. EKF Diagnostics
  • 14.7. Thermo Fisher Scientific Inc.
  • 14.8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 14.9. Randox Laboratories Ltd.
  • 14.10. QuidelOrtho Corporation

LIST NOT EXHAUSTIVE

15. Global Biochemistry Analyzers Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Application
  • 15.3. Contact Us